Trial Profile
PpIX in curetted and non-curetted skin after Metvix application
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Sep 2017
Price :
$35
*
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Actinic keratosis
- Focus Pharmacokinetics
- 01 Sep 2017 Trial has been discontinued in Denmark (end date:2017-08-21).
- 10 Feb 2017 New trial record